CORMEDIX INC. Stock Issued During Period, Shares, Period Increase (Decrease)
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CORMEDIX INC. stock issued during period, shares, period increase (decrease) for the quarter ending 2023-09-30 was 0.00 shares.
- CORMEDIX INC. stock issued during period, shares, period increase (decrease) for the quarter ending 2023-06-30 was 0.00 shares.
- CORMEDIX INC. stock issued during period, shares, period increase (decrease) for the quarter ending 2023-03-31 was 29.11K shares, a 0.00% change year-over-year.
- CORMEDIX INC. stock issued during period, shares, period increase (decrease) for the quarter ending 2022-12-31 was 0.00 shares.
- CORMEDIX INC. stock issued during period, shares, period increase (decrease) for fiscal 2022 was 29.11K shares.
| Period end | Stock Issued During Period, Shares, Period Increase (Decrease) 3 month | Stock Issued During Period, Shares, Period Increase (Decrease) 12 month |
|---|---|---|
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 29.11K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 29.11K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 29.11K shares 10-Q · filed 2023-05-15 | 29.11K shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 29.11K shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | |
| 2022-03-31 | 29.11K shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |